| Literature DB >> 33965174 |
Akshay Sharma1, Sherif M Badawy2, Elizabeth M Suelzer3, Hemant S Murthy4, Pinki Prasad5, Hesham Eissa6, Paul A Carpenter7, Mehdi Hamadani8, Myriam Labopin9, Hélène Schoemans10, André Tichelli11, Rachel Phelan12, Betty K Hamilton13, David Buchbinder14, Annie Im15, Rebecca Hunter16, Ruta Brazauskas17, Linda J Burns18.
Abstract
Systematic reviews apply rigorous methodologies to address a prespecified, clearly formulated clinical research question. The conclusion that results is often cited to more robustly inform decision making by clinicians, third-party payers, and managed care organizations about the clinical question of interest. Although systematic reviews provide a rigorous standard, they may be infeasible when the task is to create general disease-focused guidelines comprising multiple clinical practice questions versus a single major clinical practice question. Collaborating transplantation and cellular therapy society committees also recognize that the quantity and or quality of reference sources may be insufficient for a meaningful systematic review. As the conduct of systematic reviews has evolved over time in terms of grading systems, reporting requirements, and use of technology, here we provide current guidance on methodologies, resources for reviewers, and approaches to overcome challenges in conducting systematic reviews in transplantation and cellular therapy.Entities:
Keywords: Cellular therapy; Hematopoietic cell transplantation; Systematic reviews
Mesh:
Year: 2021 PMID: 33965174 PMCID: PMC8415092 DOI: 10.1016/j.jtct.2020.12.002
Source DB: PubMed Journal: Transplant Cell Ther ISSN: 2666-6367